• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • AB Science – Masitinib
      • BrainStorm Cell Therapeutics – NurOwn
      • Clene Nanomedicine – CNM-Au8
      • ILB – Tikomed
      • Kadimastem – AstroRx
      • Mitsubishi Tanabe Pharma America – Oral Edaravone
      • Neuronata-R/Lenzumestrocel
      • NeuroSense – PrimeC
      • Neuvivo – NP001
      • Prilenia Therapeutics – Pridopidine
      • SOD1 Therapies & Trials
      • SPG302
      • T Regulatory Cell Therapies
      • Ulefnersen – Ionis Pharmaceuticals
    • Approved Drugs
      • Nuedexta
      • Radicava/Edaravone
      • Riluzole/Tiglutik
      • Rozebalamin/Methylcobalamin
      • Tofersen/Qalsody
    • Drugs No Longer in Development
      • Amylyx – AMX0035
      • Collaborative Medicinal Development – CuATSM
      • Cytokinetics – Reldesemtiv
      • Orphazyme – Arimoclomol
      • TUDCA Trial
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Advisory Councils/Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Archives
      • Newsletters
      • Meetings
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Forbes Norris Award

The Forbes Norris Award was established in 1994 to honour the legacy of Dr. Forbes “Ted” Norris (1928–1993), a neurologist who dedicated his life to supporting people living with ALS/MND. This prestigious award recognizes individuals whose work advances clinical care, research, and understanding of ALS/MND for the benefit of those living with the disease.

Dolores “Dee” Holden Norris (1946–2025), Ted’s wife, championed the award and the standards of clinical excellence it represents. In December 2025, the International Alliance paid tribute to Dee — nurse, advocate, co-founder of the Alliance, and a driving force behind the multidisciplinary model of ALS/MND care.

Working alongside Ted, she helped transform how ALS/MND care is delivered worldwide. At a time when patients were often offered little more than prognosis, they envisioned something fundamentally different: coordinated, team-based care grounded in clinical excellence and compassion. Their work helped establish the global standard for multidisciplinary ALS/MND clinics and laid the foundation for the collaborative international community that exists today.

To be considered for the Forbes Norris Award, candidates must:

  • Play a major role in delivering outstanding ALS/MND patient care
  • Contribute significantly to medical literature in clinical management or basic science related to ALS/MND
  • Be part of a team engaged in ongoing research into ALS/MND care, management, or basic science

The award is presented annually during the opening ceremony of the MND Association’s International Symposium on ALS/MND. If no suitable candidate is nominated in a given year, the award will not be granted. Please note that current Board of Directors are not eligible for nomination.

The 2026 nomination period will open on July 1. 

Primary Sidebar

  • Margarita Pizarro, Argentina

    Margarita Pizarro, Argentina

  • Jette Odgaard Villemoes, Denmark

    Jette Odgaard Villemoes, Denmark

  • Daniel Hare, USA

    Daniel Hare, USA

  • Mona H. Bahus and Camilla Knoff Glomstad, Norway

    Mona H. Bahus and Camilla Knoff Glomstad, Norway

  • João Marcos Andrietta, Brazil

    João Marcos Andrietta, Brazil

  • David Bishop, UK

    David Bishop, UK

  • Diana Fernandez, Argentina

    Diana Fernandez, Argentina

  • Den Haag, Netherlands

    Den Haag, Netherlands

  • Fabio Carvalho, Brazil

    Fabio Carvalho, Brazil

  • Norm MacIsaac, Canada

    Norm MacIsaac, Canada

  • Philip Brindle, England

    Philip Brindle, England

  • Juvenal Bayona Romero, Colombia

    Juvenal Bayona Romero, Colombia

  • Chen Chun-Chin, Malaysia

    Chen Chun-Chin, Malaysia

  • Bjarne Hytjanstorp, Norway

    Bjarne Hytjanstorp, Norway

  • Rudiger Hanemann, Germany

    Rudiger Hanemann, Germany

  • Leon Ryba, Argentina

    Leon Ryba, Argentina

  • Marcelo Farinelli, Brazil

    Marcelo Farinelli, Brazil

  • Maria Santos Garcia Tellez, Mexico

    Maria Santos Garcia Tellez, Mexico

  • Natalya Rybakova, Russia

    Natalya Rybakova, Russia

  • Sam Hayden-Harler, UK

    Sam Hayden-Harler, UK

  • Laurie Petit-Jean, France

    Laurie Petit-Jean, France

  • Elkin Ramiro Gaviria Muñoz, Colombia

    Elkin Ramiro Gaviria Muñoz, Colombia

  • Animesh Kumar, India

    Animesh Kumar, India

  • Mauricio Dorin, Argentina

    Mauricio Dorin, Argentina

  • Dr. Janmejay Pradhan, India

    Dr. Janmejay Pradhan, India

  • Bruno Leanza Mantegna, Italy

    Bruno Leanza Mantegna, Italy

  • Mike Rannie, Canada

    Mike Rannie, Canada

  • Anthony Lynch, Australia

    Anthony Lynch, Australia

  • Elkin Gaviria, Colombia

    Elkin Gaviria, Colombia

  • John Dinon, Australia

    John Dinon, Australia

  • Fabrice Kamp, Germany

    Fabrice Kamp, Germany

  • Mauril Belanger, Canada

    Mauril Belanger, Canada

  • Lombana, Spain

    Lombana, Spain

  • Calum Ferguson, Scotland

    Calum Ferguson, Scotland

  • Seckin McGuirk, England

    Seckin McGuirk, England

  • Bob Simonds, USA

    Bob Simonds, USA

  • Alberto Baez Murillo, Colombia

    Alberto Baez Murillo, Colombia

  • Mauril Bélanger, Canada

    Mauril Bélanger, Canada

  • Anita Forte, USA

    Anita Forte, USA

  • Timmy, Belgium

    Timmy, Belgium

  • Steven Gallagher, Canada

    Steven Gallagher, Canada

  • Semra Gokalp, Turkey

    Semra Gokalp, Turkey

  • Andrea Zicchieri, Italy

    Andrea Zicchieri, Italy
    AndreaZicchieri_conSLAncioItaly

  • Carlos Alberto Arango, Colombia

    Carlos Alberto Arango, Colombia

  • JP

    JP

  • Steve

    Steve

  • Brigitte Wernli, Switzerland

    Brigitte Wernli, Switzerland

  • Joanne Pratt, Australia

    Joanne Pratt, Australia

  • Chris McCauley, Canada

    Chris McCauley, Canada

  • Liam Dwyer, England

    Liam Dwyer, England

Learn more about the March of Faces

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login